Prostate Cancer

Latest News

FDA logo
FDA news recap in urology for Q2 2025

July 3rd 2025

Here’s a look back at notable news between April and June 2025.

Enrollment begins in phase 2 trial of opaganib plus darolutamide in mCRPC
Enrollment begins in phase 2 trial of opaganib plus darolutamide in mCRPC

July 2nd 2025

Gedatolisib plus darolutamide shows encouraging activity in mCRPC
Gedatolisib plus darolutamide shows encouraging activity in mCRPC

July 1st 2025

FDA updates in urology: June 2025
FDA updates in urology: June 2025

July 1st 2025

What urologists can expect in Q3 of 2025
What urologists can expect in Q3 of 2025

June 30th 2025

Latest CME Events & Activities
© 2025 MJH Life Sciences

All rights reserved.